Peer Review History
| Original SubmissionJuly 15, 2023 |
|---|
|
PONE-D-23-21440Effects of Mindfulness-Based Tai Chi Chuan on Executive Functions and Mobile Phone Addiction Among Male College StudentsPLOS ONE Dear Dr. Bai, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Please find below the reviewer's comments and recommendations. We are waiting for your upgraded version of your article. Please submit your revised manuscript by Mar 31 2024 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org . When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols . Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols . We look forward to receiving your revised manuscript. Kind regards, Bogdan Nadolu, Ph.D. Academic Editor PLOS ONE Journal Requirements: When submitting your revision, we need you to address these additional requirements. 1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 2. PLOS requires an ORCID iD for the corresponding author in Editorial Manager on papers submitted after December 6th, 2016. Please ensure that you have an ORCID iD and that it is validated in Editorial Manager. To do this, go to ‘Update my Information’ (in the upper left-hand corner of the main menu), and click on the Fetch/Validate link next to the ORCID field. This will take you to the ORCID site and allow you to create a new iD or authenticate a pre-existing iD in Editorial Manager. Please see the following video for instructions on linking an ORCID iD to your Editorial Manager account: https://www.youtube.com/watch?v=_xcclfuvtxQ 3. Note from Emily Chenette, Editor in Chief of PLOS ONE, and Iain Hrynaszkiewicz, Director of Open Research Solutions at PLOS: Did you know that depositing data in a repository is associated with up to a 25% citation advantage (https://doi.org/10.1371/journal.pone.0230416)? If you’ve not already done so, consider depositing your raw data in a repository to ensure your work is read, appreciated and cited by the largest possible audience. You’ll also earn an Accessible Data icon on your published paper if you deposit your data in any participating repository (https://plos.org/open-science/open-data/#accessible-data). 4. Thank you for stating the following financial disclosure:"The work involved in this submission was supported by the R&D Program of Beijing Municipal Education Commission(KM202210029001). The fund recipient is Baishuang, who is the corresponding author of this submission." Please state what role the funders took in the study. If the funders had no role, please state: ""The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript."" If this statement is not correct you must amend it as needed. Please include this amended Role of Funder statement in your cover letter; we will change the online submission form on your behalf. 5. Please include your full ethics statement in the ‘Methods’ section of your manuscript file. In your statement, please include the full name of the IRB or ethics committee who approved or waived your study, as well as whether or not you obtained informed written or verbal consent. If consent was waived for your study, please include this information in your statement as well. 6. Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Partly Reviewer #2: Yes Reviewer #3: Yes ********** 2. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: Yes Reviewer #2: Yes Reviewer #3: I Don't Know ********** 3. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes Reviewer #2: Yes Reviewer #3: Yes ********** 4. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes Reviewer #2: Yes Reviewer #3: Yes ********** 5. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: 1.Random allocation is mentioned in the research methods section of this paper. Please clarify the specific method of random allocation. Please describe the process of assigning concealment. 2.The exercise dose in the exercise intervention Plan section proposes, “The exercise time lasts 40 min each time, including 5 min of wuji pile practice with positive thoughts, 30 min of eight styles of Tai Chi Chuan practice (4 min*6 sets, 1 min interval between sets), and 5 min of relaxation part of wuji pile with music. The exercise frequency is 3 times a week. "What is it based on, Please support this in the Introduction section. Reviewer #2: The title reads well, and the overall study design is rigorous. however 1. It is suggested to add biological charts or literature in the introduction and discussion section to better support the argument. 2. There are a lot of recent studies on mindfulness, executive function and mobile phone addiction, so you can refer to recent literatures to provide theoretical basis for this study. Reviewer #3: Manuscript review: PONE-D-23-21440 Effects of Mindfulness-Based Tai Chi Chuan on Executive Functions and Mobile Phone Addiction Among Male College Students Thank you for the opportunity to read the proposed manuscript. The issues raised by the authors touch on the socially important issue of addiction therapy. Based on indirect experiments, they indicate a significant reduction in the level of addiction to mobile phones as a result of 8 weeks of MTCC activity. The main factor is the increased cognitive inhibition and attention shown in the experimental group as a result of MTCC classes. The conclusions regarding the reduction of addiction to mobile phones are based on the results of increasing inhibition and attention. It seems that there may be some reservations as to the validity of such a conclusion. The title itself also suggests a direct link between MTCC exercises and cell phone addiction. I think this is too far of a generalization. The authors themselves indicate that various aerobic exercises, basketball and traditional Baduanjin exercises are effective in reducing mobile phone addiction among students. That is, MTCC exercises significantly increase cognitive functions, leading to increased inhibition and attentiveness, and may be helpful in the prevention of addictions, including cell phone addictions. After reading the manuscript, I offer some suggestions: - editing the title appropriately. - use of table descriptions, in accordance with the editorial guidelines - description above the table and figures below the table. - standardize the notation for presenting the significance of "p" or "P". Mediating effects test method - Statistical analyzes were all performed on SPSS 23.0 with a statistical analysis significance of p<0.05. The following text uses the notation "P" - you should consider presenting the results for both groups in a descriptive form (providing the data that is in the tables), especially in the context of the control group: “There were no significant differences between pre- and post-test correct speed (F = 0.113, P = 0.738 > 0.05) and updating reaction time (F = 0.112, P = 0.739 > 0.05) in the control group.” - conclusions: Conclusion 1 and 3 are basically the same, just composed differently. They constitute a summary of the research conducted rather than conclusions. I would suggest expanding: MTCC exercises significantly increase cognitive functions, leading to increased inhibition and attentiveness, and may be helpful in the prevention of addictions, including cell phone addictions. Lack of properly compiled literature, multiple omission of journal titles presented in the literature list: items: 2,3,4,6, 7 (item from PLOS ONE), 8,12,14 etc. Example position 20 There is: Diamond AJArop. executive functions. 2013,64:135-68. It should be: Diamond A. Executive functions. Annu Rev Psychol. 2013; 64: 135-68. doi: 10.1146/annurev-psych-113011-143750 Taking the above into account, I suggest adopting the manuscript with significant amendments. Reviewer ********** 6. PLOS authors have the option to publish the peer review history of their article (what does this mean? ). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy . Reviewer #1: Yes: Shuqiao Meng Reviewer #2: Yes: Wenxia Tong Reviewer #3: No ********** [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/ . PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org . Please note that Supporting Information files do not need this step. |
| Revision 1 |
|
PONE-D-23-21440R1The effect of Mindfulness-Based Tai Chi Chuan on Mobile Phone Addiction Among Male College Students is associated with Executive Functions.PLOS ONE Dear Dr. Bai, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version (focus on the reviewer-4 feedback) of the manuscript that addresses the points raised during the review process. Please submit your revised manuscript by Mar 23 2025 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org . When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols . Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols . We look forward to receiving your revised manuscript. Kind regards, Metin Çınaroğlu Academic Editor PLOS ONE Journal Requirement: During additional checks of this submission it has come to our attention that your study meets the WHO definition of a Clinical Trial because it is a prospective study in which participants were assigned to Tai Chi Chuan to investigate the effects on mobile phone addiction. Please change your manuscript’s article type to ‘Clinical Trial’ when you resubmit your manuscript, and address the following requests: a. Please upload a completed CONSORT flowchart as figure 1 of your manuscript. Blank copies of this document and information regarding CONSORT can be found via the following link: (https://www.equator-network.org/reporting-guidelines/consort/). b. Please upload a completed CONSORT checklist as a supporting information file. Blank copies of this document and information regarding CONSORT can be found via the following link: (https://www.equator-network.org/reporting-guidelines/consort/). If your clinical trial uses a non-randomized design, you may wish to submit a TREND checklist (http://www.cdc.gov/trendstatement), in place of the CONSORT checklist. c. Please upload a copy of your trial study protocol as a supporting information file. By the study protocol, we mean the complete and detailed plan for the conduct and analysis of the trial that the ethics committee approved before the trial began. Please send this in the original language. If this is in a language other than English, please also provide a translation. Please detail any deviations from this study protocol in the Methods section of your manuscript. Your study protocol will be made available to the editors and reviewers, and will be published as supporting information with your manuscript if accepted for publication. (If you do not agree to this, we will not be able to publish your manuscript). If you have formally published a study protocol for your trial in a journal then you should cite this in your manuscript, but you still need to send us the original document. Your study protocol will be made available to the editors and reviewers, and will be published as supporting information with your manuscript if accepted for publication. (If you do not agree to this, we will not be able to publish your manuscript). d. PLOS ONE requires that all clinical trials are registered in an appropriate registry (the WHO list of approved registries is at https://www.who.int/clinical-trials-registry-platform/network/primary-registries" https://www.who.int/clinical-trials-registry-platform/network/primary-registries and more information on trial registration is at http://www.icmje.org/about-icmje/faqs/clinical-trials-registration/). Please state the name of the registry and the registration number (e.g. ISRCTN or ClinicalTrials.gov) in the submission data and on the title page of your manuscript. i) Please provide the complete date range for participant recruitment and follow-up in the methods section of your manuscript. ii) If you have not yet registered your trial in an appropriate registry, we now require you to do so and will need confirmation of the trial registry number before we can pass your paper to the next stage of review. Please include in the Methods section of your paper your reasons for not registering this study before enrolment of participants started. Please confirm that all related trials are registered by stating: “The authors confirm that all ongoing and related trials for this drug/intervention are registered”. Please see http://journals.plos.org/plosone/s/submission-guidelines#loc-clinical-trials for our policies on clinical trials. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation. Reviewer #1: All comments have been addressed Reviewer #4: (No Response) ********** 2. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Yes Reviewer #4: Partly ********** 3. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: Yes Reviewer #4: Yes ********** 4. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes Reviewer #4: Yes ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes Reviewer #4: Yes ********** 6. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: Thank you for submitting your research article titled "The Effect of Mindfulness-Based Tai Chi Chuan on Mobile Phone Addiction Among Male College Students is Associated with Executive Functions." I have thoroughly enjoyed reading your work and believe that it addresses a significant and timely issue. I believe your article is a high-quality piece of research and is well-suited for publication in this journal. Thank you for your valuable contribution to this field. I look forward to seeing more of your work in the future. Reviewer #4: Dear Editor, Thanks for the opportunity to review this manuscript The current study aims to investigate the effects of an 8-week Mindfulness-based Tai Chi Chuan (MTCC) intervention on executive function, mindfulness levels, and mobile phone addiction in male college students. In addition, the study explored the role of executive function in improving mobile phone addiction through MTCC interventions. Abstract The results showed the F-test statistic and the corresponding p-values, but what is really important in intervention studies is the mean estimate of the outcome measures for the intervention group and control group, and the mean difference attributable to the intervention and p-value indicating where the difference is statistically significant. This information are missing from the results section of the abstract. Again, Authors must define r and F at first, used under the abstract section Method: Major concern This is an intervention study, but there was no rigorous power analysis (sample size estimation) to determine the number of Individuals with a Mobile Phone Addiction Index (MPAI) of more than 40 to be included in this study before the random assignment of these students into the intervention and control. Power analysis must be based on the minimum detectable effect expected of the intervention, power of the study, type I error, non-response rate, or attrition. Since no formal power analysis was conducted, it is difficult to determine whether the study was powered enough to address the research question. There was no information on how authors arrived at the number 66 and randomized them into intervention and control (33 each). There was no information on how the male students were selected from a pool of male students from the University in Beijing. This has a significant effect on the external validity of the study design. Which sampling frame of male students was used? Clearly state the type of model(s) used in the mediation analysis (linear regression, structural equation, etc). Results Very important information is missing from Table 2. The mean difference between the pre-test and post-test for the intervention group is missing, and the Mean difference between the pre-test and post-test for the control group is missing. Finally, difference in difference estimate is also missing. Figure 2. * and ## must not be on the graph itself. Replace that with the estimate p-values. There is no need to define that again, same as figure 3 ********** 7. PLOS authors have the option to publish the peer review history of their article (what does this mean? ). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy . Reviewer #1: Yes: Shu-qiao Meng Reviewer #4: No ********** [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/ . PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org . Please note that Supporting Information files do not need this step. |
| Revision 2 |
|
The effect of Mindfulness-Based Tai Chi Chuan on Mobile Phone Addiction Among Male College Students is associated with Executive Functions PONE-D-23-21440R2 Dear Dr. Bai, We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements. Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication. An invoice will be generated when your article is formally accepted. Please note, if your institution has a publishing partnership with PLOS and your article meets the relevant criteria, all or part of your publication costs will be covered. Please make sure your user information is up-to-date by logging into Editorial Manager at Editorial Manager® and clicking the ‘Update My Information' link at the top of the page. If you have any questions relating to publication charges, please contact our Author Billing department directly at authorbilling@plos.org. If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. Kind regards, Metin Çınaroğlu Academic Editor PLOS ONE Additional Editor Comments (optional): Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation. Reviewer #4: All comments have been addressed ********** 2. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #4: Yes ********** 3. Has the statistical analysis been performed appropriately and rigorously? Reviewer #4: Yes ********** 4. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #4: Yes ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #4: Yes ********** 6. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #4: The authors have diligently addressed all the comments especially those related to methodology and also provided clarity when the need arises ********** 7. PLOS authors have the option to publish the peer review history of their article (what does this mean? ). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy . Reviewer #4: No ********** |
| Formally Accepted |
|
PONE-D-23-21440R2 PLOS ONE Dear Dr. Bai, I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now being handed over to our production team. At this stage, our production department will prepare your paper for publication. This includes ensuring the following: * All references, tables, and figures are properly cited * All relevant supporting information is included in the manuscript submission, * There are no issues that prevent the paper from being properly typeset You will receive further instructions from the production team, including instructions on how to review your proof when it is ready. Please keep in mind that we are working through a large volume of accepted articles, so please give us a few days to review your paper and let you know the next and final steps. Lastly, if your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. If we can help with anything else, please email us at customercare@plos.org. Thank you for submitting your work to PLOS ONE and supporting open access. Kind regards, PLOS ONE Editorial Office Staff on behalf of Dr. Metin Çınaroğlu Academic Editor PLOS ONE |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .